I am an Associate Researcher of CONICET, and my research is focused on the molecular mechanisms governing tumor growth and progression, cell migration, invasion and metastasis in breast cancer. I have a broad background in molecular biology applied to precision medicine, with specific focus on identifying tumor markers in dysregulated/overactivated pathways involved in tumorigenesis, specifically in signaling pathways, both non-genomic and genomic, activated by steroid hormones, retinoic acid, protein kinases, and phosphatases. Over the course of my career, I have successfully identified novel signalling pathways and molecular therapeutic targets, such as Focal Adhesion Kinase (FAK), evaluating their potential to counteract cell invasiveness and drug resistance.
I am an Associate Researcher of CONICET, and my research is focused on the molecular mechanisms governing tumor growth and progression, cell migration, invasion and metastasis in breast cancer. I have a broad background in molecular biology applied to precision medicine, with specific focus on identifying tumor markers in dysregulated/overactivated pathways involved in tumorigenesis, specifically in signaling pathways, both non-genomic and genomic, activated by steroid hormones, retinoic acid, protein kinases, and phosphatases. Over the course of my career, I have successfully identified novel signalling pathways and molecular therapeutic targets, such as Focal Adhesion Kinase (FAK), evaluating their potential to counteract cell invasiveness and drug resistance.